Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus - PubMed (original) (raw)
Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus
Joel H Rubenstein et al. Am J Gastroenterol. 2008 Apr.
Free article
Abstract
Background: Gastroenterologists' approach to surveillance for Barrett's esophagus is variable. We hypothesized that financial incentives and concerns over malpractice litigation influence gastroenterologists' usual practices regarding screening and surveillance.
Methods: We surveyed gastroenterologists (N = 224) regarding their usual practice of screening or surveillance for Barrett's esophagus, belief in the efficacy of screening, knowledge of published guidelines, demographic factors, compensation structure, volume of endoscopies, and malpractice history. Practices were characterized as aggressive or conservative in the utilization of services compared with a published guideline.
Results: Twenty-one percent of attending gastroenterologists reported being identified as a defendant in at least one malpractice suit. Prior malpractice defendants had practiced gastroenterology longer and performed a higher volume of endoscopies, but had similar knowledge regarding published screening guidelines to those who had not been defendants. They were more likely to be aggressive rather than conservative in screening and surveillance for Barrett's esophagus (odds ratio [OR] 3.6, 95% confidence interval [CI] 1.1-12), and remained so after controlling for other factors. In particular, they were more likely to recommend screening for populations with a lower risk of development of cancer, and to perform more frequent surveillance for low-grade dysplasia. Other factors were not associated with aggressive practice, including compensation structure.
Conclusions: History of at least one prior malpractice suit appears to be associated with the more aggressive use of endoscopic screening and surveillance for Barrett's esophagus, irrespective of physician belief regarding the efficacy of that strategy in reducing mortality. Hypervigilance and fear of future malpractice suits may drive this increased use.
Similar articles
- Reasons for current practices in managing Barrett's esophagus.
Lin OS, Mannava S, Hwang KL, Triadafilopoulos G. Lin OS, et al. Dis Esophagus. 2002;15(1):39-45. doi: 10.1046/j.1442-2050.2002.00221.x. Dis Esophagus. 2002. PMID: 12060041 - A survey of Canadian gastroenterologists about the management of Barrett's esophagus.
MacNeil-Covin L, Casson AG, Malatjalian D, Veldhuyzen van Zanten S. MacNeil-Covin L, et al. Can J Gastroenterol. 2003 May;17(5):313-7. doi: 10.1155/2003/648497. Can J Gastroenterol. 2003. PMID: 12772005 - Management of Barrett's oesophagus in 2001 in Ireland.
Moss A, Clarke E, Crowe J, Lennon J, Mac Mathuna P. Moss A, et al. Ir J Med Sci. 2003 Oct-Dec;172(4):174-6. doi: 10.1007/BF02915284. Ir J Med Sci. 2003. PMID: 15029984 - Screening and surveillance of Barrett's esophagus.
Regula J. Regula J. Dig Dis. 2009;27(1):54-7. doi: 10.1159/000210104. Epub 2009 May 8. Dig Dis. 2009. PMID: 19439961 Review. - Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ. Spechler SJ. Am J Med. 2001 Dec 3;111 Suppl 8A:130S-136S. doi: 10.1016/s0002-9343(01)00851-8. Am J Med. 2001. PMID: 11749938 Review.
Cited by
- Precision prevention of oesophageal adenocarcinoma.
Vaughan TL, Fitzgerald RC. Vaughan TL, et al. Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):243-8. doi: 10.1038/nrgastro.2015.24. Epub 2015 Feb 10. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25666644 Free PMC article. Review. - Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
Sijben J, Rainey L, Peters Y, Fitzgerald RC, Wani S, Kolb JM, Broeders MJM, Siersema PD. Sijben J, et al. BMC Cancer. 2023 Nov 14;23(1):1111. doi: 10.1186/s12885-023-11583-x. BMC Cancer. 2023. PMID: 37964213 Free PMC article. - Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM. Rubenstein JH, et al. Am J Gastroenterol. 2011 Feb;106(2):254-60. doi: 10.1038/ajg.2010.470. Epub 2010 Dec 7. Am J Gastroenterol. 2011. PMID: 21139576 Free PMC article. - Barrett esophagus and life expectancy: implications for screening?
Kuipers EJ. Kuipers EJ. Gastroenterol Hepatol (N Y). 2011 Oct;7(10):689-91. Gastroenterol Hepatol (N Y). 2011. PMID: 22298963 Free PMC article. No abstract available. - A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus?
Crockett SD, Barritt AS 4th, Shaheen NJ. Crockett SD, et al. Clin Gastroenterol Hepatol. 2010 Jul;8(7):565-71. doi: 10.1016/j.cgh.2009.11.013. Epub 2009 Dec 3. Clin Gastroenterol Hepatol. 2010. PMID: 19948248 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources